ProQR Therapeutics N.V.

(PRQR) Trade

By |

Profile

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313. Its product pipeline includes QRX-704, QRX-504, QRX-421, QRX-323 etc.

Contact Information

Website: www.proqr.com
Email: info@proqr.com
Main Phone: +31 881667000
Address: Zernikedreef 9
City / Town: Leiden
Country: NLD
Postal Code: 2333 CK

Issuer Information

Exchange: NSD
CEO: Daniel de Boer
Employees: 130
$ 18.00 $ 0.03 (0.17%)
Last Price 18.00 Change $ 0.03 Change % 0.17 Tick N/A
Bid 10.50 Bid Size 200.00 Ask 24.20 Ask Size 100.00
Open 17.88 High 18.23 Low 17.64 Prev Close 17.97
Last Trade Volume 210,305 52 Wk Hi 24.00 52 Wk Low 2.80
Market Cap 696.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 38,715,563.00 EPS (TTM) -1.40 PE Ratio N/A Exchange NSD
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 20 20 20 20
Low Target Price Estimate 4.5 4.5 4.5 4.5
Mean Target Price Estimate 12.25 12.25 12.25 12.25
Standard Deviation 10.96 10.96 10.96 10.96
Date of Most Recent Estimate 04/05/18 04/05/18 04/05/18 04/05/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1